Live feed16:12:51·48mINSIDERFilingvia QuantisnowChief Operating Officer Neervannan Seshadri sold $387,940 worth of shares (4,564 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 78,532 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TARS· Tarsus Pharmaceuticals Inc.Health CareOriginal source